Finished
A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy
NCT04574401 · Intuitive Surgical · Updated 22 Oct 2021
- What is being tested
- IS-002
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 1.
- Who can join
- Ages 18 years to 75 years. About 24 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 10 Oct 2020, ends 20 Sept 2021. Registered 5 Oct 2020.
- Results
- None posted yet.
In the researchers' words
This is a Phase 1, single-site, interventional clinical trial evaluating the safety and efficacy of IS-002 intravenous (IV) injection for fluorescent identification and delineation of the positive cancer margins and metastatic lymph nodes during prostatectomy surgery using the da Vinci® X/Xi Surgical System with Firefly® Fluorescent Imaging.
Sites
- UCSF Medical Center, Mission BaySan Francisco, California, United States